OBJECTIVE: We sought to estimate how serosorting may affect HIV prevalence and individual risk among men who have sex with men in Seattle, Washington, and how the results vary under different assumptions of HIV testing frequency, heterogeneity in sexual behavior, and condom use. METHODS: We developed a deterministic mathematical model of HIV transmission dynamics. Data from the 2003 random digit dial study of men who have sex with men conducted in Seattle, Washington (n = 400) are used to parameterize the model. RESULTS: Predicted population-level HIV prevalence as well as an individual's risk of HIV acquisition decreases when the odds of serosorting are increased in the mathematical model. In our model based on observed levels of serosorting, we predict an HIV prevalence of 16%. In contrast, if serosorting were eliminated in the population, we predict that HIV prevalence would increase to 24.5%. However, our findings depend on rates of condom use, mean anal sex contact rates, and HIV testing in the population. CONCLUSION: Under realistic scenarios of sexual behavior and testing frequency for men who have sex with men in the United States, serosorting can be an effective harm reduction strategy.
OBJECTIVE: We sought to estimate how serosorting may affect HIV prevalence and individual risk among men who have sex with men in Seattle, Washington, and how the results vary under different assumptions of HIV testing frequency, heterogeneity in sexual behavior, and condom use. METHODS: We developed a deterministic mathematical model of HIV transmission dynamics. Data from the 2003 random digit dial study of men who have sex with men conducted in Seattle, Washington (n = 400) are used to parameterize the model. RESULTS: Predicted population-level HIV prevalence as well as an individual's risk of HIV acquisition decreases when the odds of serosorting are increased in the mathematical model. In our model based on observed levels of serosorting, we predict an HIV prevalence of 16%. In contrast, if serosorting were eliminated in the population, we predict that HIV prevalence would increase to 24.5%. However, our findings depend on rates of condom use, mean anal sex contact rates, and HIV testing in the population. CONCLUSION: Under realistic scenarios of sexual behavior and testing frequency for men who have sex with men in the United States, serosorting can be an effective harm reduction strategy.
Authors: Beryl A Koblin; Margaret A Chesney; Marla J Husnik; Sam Bozeman; Connie L Celum; Susan Buchbinder; Kenneth Mayer; David McKirnan; Franklyn N Judson; Yijian Huang; Thomas J Coates Journal: Am J Public Health Date: 2003-06 Impact factor: 9.308
Authors: Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch Journal: AIDS Date: 2003-09-05 Impact factor: 4.177
Authors: Hanne Thiede; Richard A Jenkins; James W Carey; Rebecca Hutcheson; Katherine K Thomas; Ronald D Stall; Edward White; Iris Allen; Roberto Mejia; Matthew R Golden Journal: Am J Public Health Date: 2008-04-29 Impact factor: 9.308
Authors: Travis C Porco; Jeffrey N Martin; Kimberly A Page-Shafer; Amber Cheng; Edwin Charlebois; Robert M Grant; Dennis H Osmond Journal: AIDS Date: 2004-01-02 Impact factor: 4.177
Authors: Matthew R Golden; Devon D Brewer; Ann Kurth; King K Holmes; H Hunter Handsfield Journal: J Acquir Immune Defic Syndr Date: 2004-06-01 Impact factor: 3.731
Authors: J Carlo Hojilla; Kimberly A Koester; Stephanie E Cohen; Susan Buchbinder; Deawodi Ladzekpo; Tim Matheson; Albert Y Liu Journal: AIDS Behav Date: 2016-07
Authors: David M Moore; Steve Kanters; Warren Michelow; Reka Gustafson; Robert S Hogg; Michael Kwag; Terry Trussler; Marissa McGuire; Wayne Robert; Mark Gilbert Journal: Can J Public Health Date: 2012 Mar-Apr
Authors: Cristina Rodriguez-Hart; Hongjie Liu; Rebecca G Nowak; Ifeanyi Orazulike; Sam Zorowitz; Trevor A Crowell; Stefan D Baral; William Blattner; Man Charurat Journal: AIDS Behav Date: 2016-11
Authors: Narat Punyacharoensin; William John Edmunds; Daniela De Angelis; Richard Guy White Journal: Eur J Epidemiol Date: 2011-09-20 Impact factor: 8.082